Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.


Journal Article

We examined current outcomes of unrelated donor allogeneic hematopoietic cell transplantation (HCT) to determine the clinical implications of donor-recipient HLA matching. Adult and pediatric patients who had first undergone myeloablative-unrelated bone marrow or peripheral blood HCT for acute myelogenous leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, and myelodysplastic syndrome between 1999 and 2011 were included. All had high-resolution typing for HLA-A, -B, -C, and -DRB1. Of the total (n = 8003), cases were 8/8 (n = 5449), 7/8 (n = 2071), or 6/8 (n = 483) matched. HLA mismatch (6-7/8) conferred significantly increased risk for grades II to IV and III to IV acute graft vs host disease (GVHD), chronic GVHD, transplant-related mortality (TRM), and overall mortality compared with HLA-matched cases (8/8). Type (allele/antigen) and locus (HLA-A, -B, -C, and -DRB1) of mismatch were not associated with overall mortality. Among 8/8 matched cases, HLA-DPB1 and -DQB1 mismatch resulted in increased acute GVHD, and HLA-DPB1 mismatch had decreased relapse. Nonpermissive HLA-DPB1 allele mismatch was associated with higher TRM compared with permissive HLA-DPB1 mismatch or HLA-DPB1 match and increased overall mortality compared with permissive HLA-DPB1 mismatch in 8/8 (and 10/10) matched cases. Full matching at HLA-A, -B, -C, and -DRB1 is required for optimal unrelated donor HCT survival, and avoidance of nonpermissive HLA-DPB1 mismatches in otherwise HLA-matched pairs is indicated.

Full Text

Duke Authors

Cited Authors

  • Pidala, J; Lee, SJ; Ahn, KW; Spellman, S; Wang, H-L; Aljurf, M; Askar, M; Dehn, J; Fernandez Viña, M; Gratwohl, A; Gupta, V; Hanna, R; Horowitz, MM; Hurley, CK; Inamoto, Y; Kassim, AA; Nishihori, T; Mueller, C; Oudshoorn, M; Petersdorf, EW; Prasad, V; Robinson, J; Saber, W; Schultz, KR; Shaw, B; Storek, J; Wood, WA; Woolfrey, AE; Anasetti, C

Published Date

  • October 16, 2014

Published In

Volume / Issue

  • 124 / 16

Start / End Page

  • 2596 - 2606

PubMed ID

  • 25161269

Pubmed Central ID

  • 25161269

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

Digital Object Identifier (DOI)

  • 10.1182/blood-2014-05-576041


  • eng

Conference Location

  • United States